Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical ...
Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.
ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to ...
Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...
In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...
ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...
Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback